Collins; Steven J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Collins; Steven J..The latest application filed is for "cam kinase ii inhibitor improves retinoic acid therapy and inhibits the proliferation of myeloid leukemia cells".
- Collins; Steven J. - Lake Forest Park WA
- Collins; Steven J. - Seattle WA
- Collins; Steven J. - Cranston RI
| Patent | Date |
|---|---|
| CaM Kinase II Inhibitor Improves Retinoic Acid Therapy and Inhibits the Proliferation of Myeloid Leukemia Cells App 20080255244 - Collins; Steven J. ; et al. | 2008-10-16 |
| Creating novel hematopoietic cell lines by expressing altered retinoic acid receptors Grant 5,830,760 - Tsai , et al. November 3, 1 | 1998-11-03 |
| Writing implement Grant D369,184 - Collins April 23, 1 | 1996-04-23 |
| Combination writing instrument and bookmark Grant D355,933 - Collins February 28, 1 | 1995-02-28 |
| NCAGE Code | 4EC68 | COLLINS STEVEN J |
| CAGE Code | 4EC68 | COLLINS, STEVEN J |
| SEC | 0001310177 | Collins Steven J |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 